Ian Dixon
Förmögenhet: 4 M $ per 2026-07-31
Förmögenhet: 4 M $ per 2026-07-31
Ian Dixon was the founder of Genscreen Pty Ltd. founded in 2002, Cynata, Inc. founded in 2011, Exopharm Ltd. founded in 2013 where Dr. Dixon was Chief Executive Officer, Director & MD from 2013 to 2024, and Cardio Therapeutics Pty Ltd. founded in 2014.
Dr. Dixon is currently Managing Director at Altnia Holdings Pty Ltd., Independent Non-Executive Director at Nyrada, Inc. since 2020, and a Member of the Australia Institute of Co. Directors.
Former positions include Executive Director at Medigard Ltd., Director-Product Group at Vision Systems Pty Ltd., Non-Executive Director at Cell Therapies Pty Ltd., Non-Executive Director at Noxopharm Ltd. from 2016 to 2020, and Owner at Cynata Therapeutics Ltd. Education includes a doctorate from Monash University and undergraduate and MBAistration degrees from Swinburne University of Technology.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
NYRADA, INC. 8,94 % | 2026-02-20 | 9 780 699 ( 8,94 % ) | 4 M $ | 2026-07-31 |
| Företag | Position | Start |
|---|---|---|
| NYRADA INC. | Direktör/Styrelseledamot | 2020-09-01 |
Altnia Holdings Pty Ltd.
Altnia Holdings Pty Ltd. Investment ManagersFinance Provides investment services | Företagsledare/Principal | - |
Australia Institute of Co. Directors | Företagsledare/Principal | - |
| Företag | Position | Slut |
|---|---|---|
| EXOPHARM | Grundare | 2024-05-01 |
| NOXOPHARM LIMITED | Direktör/Styrelseledamot | 2020-08-31 |
Genscreen Pty Ltd. | Grundare | 2018-01-01 |
| CYNATA THERAPEUTICS LIMITED | Företagsledare/Principal | - |
Cardio Therapeutics Pty Ltd.
Cardio Therapeutics Pty Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Grundare | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 14 |
|---|---|
Medigard Ltd.
Medigard Ltd. Packaged SoftwareTechnology Services Engages in the development of innovative medical technologies | Technology Services |
Vision Systems Pty Ltd.
Vision Systems Pty Ltd. Medical SpecialtiesHealth Technology Develops, manufactures, & distributes technology products and services to healthcare markets | Health Technology |
Monash University
Monash University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Swinburne University of Technology
Swinburne University of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cynata Therapeutics Ltd.
Cynata Therapeutics Ltd. BiotechnologyHealth Technology Engages in stem cell research and development services | Health Technology |
Cell Therapies Pty Ltd. | |
Australia Institute of Co. Directors | |
Cynata, Inc.
Cynata, Inc. Miscellaneous Commercial ServicesCommercial Services Engaged in stem cell research and development services | Commercial Services |
Genscreen Pty Ltd. | |
Noxopharm Ltd.
Noxopharm Ltd. Pharmaceuticals: MajorHealth Technology Develops drugs for cancer treatment | Health Technology |
Altnia Holdings Pty Ltd.
Altnia Holdings Pty Ltd. Investment ManagersFinance Provides investment services | Finance |
Cardio Therapeutics Pty Ltd.
Cardio Therapeutics Pty Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Nyrada, Inc.
Nyrada, Inc. Pharmaceuticals: MajorHealth Technology Operates as pre-clinical stage drug development company, specializes in development of novel small molecule drugs | Health Technology |
Exopharm Ltd.
Exopharm Ltd. Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of exosomes as therapeutic agent | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån